AlphaGrep UK Ltd’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$586K Sell
1,239
-494
-29% -$249K 0.17% 169
2025
Q4
$809K Buy
+1,733
New +$805K 0.27% 63

Other funds holding HCA

AlphaGrep UK Ltd's HCA Position: Q1 2026 in Review

AlphaGrep UK Ltd reduced its HCA Healthcare (HCA) stake by 29% in Q1 2026, selling an estimated $249K and leaving 1,239 shares worth $586K. The position accounts for 0.17% of the portfolio, ranked #169.

AlphaGrep UK Ltd first reported a position in HCA in Q4 2025 and has held it in 2 quarters since. The position peaked at $809K in Q4 2025. 1,420 funds tracked by Wall St. Rank hold HCA as of Q1 2026.

  • AlphaGrep UK Ltd held 1,239 shares of HCA Healthcare worth $586K as of Q1 2026.
  • AlphaGrep UK Ltd sold 494 HCA Healthcare shares in Q1 2026, an estimated $249K.
  • HCA Healthcare made up 0.17% of AlphaGrep UK Ltd's portfolio in Q1 2026, its #169 holding.
  • AlphaGrep UK Ltd first reported a position in HCA Healthcare in Q4 2025 and has held it in 2 quarters since.
  • AlphaGrep UK Ltd's HCA Healthcare position peaked at $809K in Q4 2025.
  • 1,420 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.

Based on AlphaGrep UK Ltd's 13F filing for Q1 2026, filed 13 Aug 2026.